Vectormune FP-LT+AE (Canada)This page contains information on Vectormune FP-LT+AE for veterinary use.
The information provided typically includes the following:
- Vectormune FP-LT+AE Indications
- Warnings and cautions for Vectormune FP-LT+AE
- Direction and dosage information for Vectormune FP-LT+AE
Vectormune FP-LT+AEThis treatment applies to the following species:
AVIAN ENCEPHALOMYELITIS-FOWL POX-LARYNGOTRACHEITIS VACCINE
Live virus, live fowl pox vector
Vectormune® FP-LT+AE contains a genetically engineered, live virus vaccine for the vaccination of chickens as an aid in the prevention of fowl pox and laryngotracheitis. The vaccine also contains a conventional live virus for vaccination as an aid in the prevention of avian encephalomyelitis. The fowl pox vaccine has been genetically engineered to contain and express key protective laryngotracheitis virus antigens.
Vectormune FP-LT+AE Caution
Federal regulations prohibit repackaging or sale of the contents of this package in fractional units. Do not accept if seal is broken.
WarningStore vaccine at 2 - 7°C (35 - 45°F). Do not vaccinate within 21 days of slaughter. Use entire contents immediately after rehydrating. Burn containers and all unused contents. Contains gentamicin and amphotericin B as preservatives. For veterinary use only.
Vectormune FP-LT+AE Indications
Administer by wing web to healthy, susceptible chickens at least eight weeks old but at least four weeks prior to the start of egg production. Chickens receiving this vaccine must not have been previously vaccinated with a fowl pox vaccine.
Dosage and AdministrationRemove seal and stopper from vaccine vial and diluent vial. Pour entire contents of diluent vial into vaccine vial, insert stopper, and shake well. The vaccine is ready for use and should be used within one hour. Hold each individual bird and spread the wing with the underside facing up. Dip the two-pronged wing web applicator into the vaccine so that the grooves fill with liquid and deliver 0.01 ml per bird. Insert the double-pronged applicator into the web portion of the wing avoiding blood vessels, muscle, and bone. Seven to ten days after vaccination, observe several chickens for evidence of “takes” that include swelling and/or scab formation at the site of injection.
Patent No. U.S. 6312696
10 x 1000 DOSES
Manufactured By: BIOMUNE CO., Lenexa, Kansas 66215 USA
Phone (913) 894-0230
U.S. Vet Lic. No. 368
Distributed By: Ceva Animal Health, Guelph, Ontario N1K 1E8
NAC No.: 12211000
6-1040 FOUNTAIN ST. N., CAMBRIDGE, ON, N3E 1A3
|Every effort has been made to ensure the accuracy of the Vectormune FP-LT+AE information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10